SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-107161
Filing Date
2023-10-05
Accepted
2023-10-05 16:04:38
Documents
12
Period of Report
2023-10-05
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327767d1_8k.htm   iXBRL 8-K 27642
  Complete submission text file 0001104659-23-107161.txt   200541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20231005.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20231005_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20231005_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2327767d1_8k_htm.xml XML 3241
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 231311347
SIC: 2834 Pharmaceutical Preparations